Creative Commons source reading · ALS and frontotemporal degeneration
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature.
Elisa Longinetti; Fang Fang
Originally published in Current opinion in neurology · 2019-10-01
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Purpose of review The cause of amyotrophic lateral sclerosis (ALS) remains unknown for most of the patients with the disease. Epidemiologic studies can help describe disease burden and examine its potential risk factors, providing thereby evidence base for future mechanistic studies. With this review, we aimed to provide a summary of epidemiologic studies published during the past 18 months, which studied the incidence and risk factors for ALS. Recent findings An increasing incidence and prevalence of ALS continue to be reported from different parts of the world. Several previously studied risk factors are confirmed as causally related to ALS by Mendelian randomization analysis. The previously known prognostic indicators for ALS appear to be the same across populations. Summary Provided with the increasing number of patients diagnosed with ALS and the improved societal awareness of the disease, more resources should be allocated to the research and care of ALS. Population-based studies, especially population-based disease registers, should be the priorities in ALS research, and more data from outside Europe are needed in gaining a better global perspective of the disease.
CONCLUSION AND IMPLICATIONS
In summary, the literature during the past 18 months has contributed importantly to our understanding of the epidemiology of ALS, especially in terms of disease burden in populations outside Europe and potential risk factors that are causally related to ALS. High-quality population-based studies or population-based disease registers are clearly needed from outside Europe to gain a better estimate of the disease burden and understanding of ALS risk factors globally.
Editorial reading guide
- Was the evidence cross-sectional, longitudinal or experimental?
- How did the authors account for age, disease stage and differences among participants?
